The Journal of Experimental Medicine · 2009 · 670 citations · 21 references
Life SciencesImmunologyOncologyCancer ImmunologyInnate ImmunityTumor ImmunologyCytokines In Tumor ImmunityNatural Killer Cell BiologyNatural Killer Cell FunctionB7 Family Immunoregulatory LigandsCell-cell RecognitionHost Cell TransformationImmune Cell CytotoxicityInnate Antitumor ImmunityInnate Immunity PathwaysNatural Killer Cell Cytokine ResponsesNk Cell Activating Ligands
Cancer development is often associated with the lack of specific and efficient recognition of tumor cells by the immune system. Natural killer (NK) cells are lymphocytes of the innate immune system that participate in the elimination of tumors. We report the identification of a tumor cell surface molecule that binds NKp30, a human receptor which triggers antitumor NK cell cytotoxicity and cytokine secretion. This previously unannotated gene belongs to the B7 family and, hence, was designated B7-H6. B7-H6 triggers NKp30-mediated activation of human NK cells. B7-H6 was not detected in normal human tissues but was expressed on human tumor cells, emphasizing that the expression of stress-induced self-molecules associated with cell transformation serves as a mode of cell recognition in innate immunity.
21
Selective rejection of H–2-deficient lymphoma variants suggests alternative immune defence strategy
Klas Kärre, Hans Ljunggren, Gerald E. Piontek et al. · Nature · 1986 · 2.1K citations
Life Sciences, Immunology, Oncology +12
Daniela Pende, Silvia Parolini, Anna Pessino et al. · The Journal of Experimental Medicine · 1999 · 767 citations · Full text
The binding site for C1q on IgG
Alexander Duncan, Greg Winter · Nature · 1988 · 562 citations
Daniela Pende, Paola Rivera, Stefania Marcenaro et al. · PubMed · 2002 · 504 citations
Life Sciences, Immunology, Oncology +17